| Elena Baltag, MD | |
|
800 W Central Rd, Arlington Heights, IL 60005-2349 | |
| (877) 635-9229 | |
| (847) 618-3259 |
| Full Name | Elena Baltag |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Location | 800 W Central Rd, Arlington Heights, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437718442 | NPI | - | NPPES |
| 036160512 | Other | IL | STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 036160512 (Illinois) | Secondary |
| 208M00000X | Hospitalist | 036160512 (Illinois) | Primary |
| Entity Name | Northshore University Healthsystem Faculty Practice Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497701882 PECOS PAC ID: 2163334699 Enrollment ID: O20040524000118 |
News Archive
New treatments are offering the prospect of eating without fear for the 15 million people in the United States with food allergies, according to the cover story in the current issue of Chemical & Engineering News.
A new Tel Aviv University study pinpoints the inverse correlation between a known oncogene - a gene that promotes the development of cancer - and the expression of an oncosuppressor microRNA as the reason for extended pancreatic cancer survival.
Boston Scientific Corporation today announced that the U.S. Court of Appeals for the Federal Circuit affirmed the decision of the U.S. District Court for the District of Delaware, finding all four patents in a suit involving Johnson & Johnson to be invalid.
The cardiovascular benefits of the diabetes drug dapagliflozin extend across a wide spectrum of patients and are especially pronounced in those with reduced ejection fraction, a measure of the heart's pumping ability indicative of poor heart functioning, according to research presented at the American College of Cardiology's 68thAnnual Scientific Session.
Clinigen Group plc, the global pharmaceutical and services company, announces that its Clinical Trial Service business has extended its exclusive European clinical trial supply agreement with Accord Healthcare. Clinigen is also offering pharma companies an ‘on demand' service to Accord's products, a first for the industry.
› Verified 5 days ago
| Entity Name | Presence Healthcare Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932216819 PECOS PAC ID: 2860396769 Enrollment ID: O20050215000965 |
News Archive
New treatments are offering the prospect of eating without fear for the 15 million people in the United States with food allergies, according to the cover story in the current issue of Chemical & Engineering News.
A new Tel Aviv University study pinpoints the inverse correlation between a known oncogene - a gene that promotes the development of cancer - and the expression of an oncosuppressor microRNA as the reason for extended pancreatic cancer survival.
Boston Scientific Corporation today announced that the U.S. Court of Appeals for the Federal Circuit affirmed the decision of the U.S. District Court for the District of Delaware, finding all four patents in a suit involving Johnson & Johnson to be invalid.
The cardiovascular benefits of the diabetes drug dapagliflozin extend across a wide spectrum of patients and are especially pronounced in those with reduced ejection fraction, a measure of the heart's pumping ability indicative of poor heart functioning, according to research presented at the American College of Cardiology's 68thAnnual Scientific Session.
Clinigen Group plc, the global pharmaceutical and services company, announces that its Clinical Trial Service business has extended its exclusive European clinical trial supply agreement with Accord Healthcare. Clinigen is also offering pharma companies an ‘on demand' service to Accord's products, a first for the industry.
› Verified 5 days ago
| Entity Name | Northwest Community Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134433154 PECOS PAC ID: 3375737331 Enrollment ID: O20101103000837 |
News Archive
New treatments are offering the prospect of eating without fear for the 15 million people in the United States with food allergies, according to the cover story in the current issue of Chemical & Engineering News.
A new Tel Aviv University study pinpoints the inverse correlation between a known oncogene - a gene that promotes the development of cancer - and the expression of an oncosuppressor microRNA as the reason for extended pancreatic cancer survival.
Boston Scientific Corporation today announced that the U.S. Court of Appeals for the Federal Circuit affirmed the decision of the U.S. District Court for the District of Delaware, finding all four patents in a suit involving Johnson & Johnson to be invalid.
The cardiovascular benefits of the diabetes drug dapagliflozin extend across a wide spectrum of patients and are especially pronounced in those with reduced ejection fraction, a measure of the heart's pumping ability indicative of poor heart functioning, according to research presented at the American College of Cardiology's 68thAnnual Scientific Session.
Clinigen Group plc, the global pharmaceutical and services company, announces that its Clinical Trial Service business has extended its exclusive European clinical trial supply agreement with Accord Healthcare. Clinigen is also offering pharma companies an ‘on demand' service to Accord's products, a first for the industry.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elena Baltag, MD 800 W Central Rd, Arlington Heights, IL 60005-2349 Ph: (877) 635-9229 | Elena Baltag, MD 800 W Central Rd, Arlington Heights, IL 60005-2349 Ph: (877) 635-9229 |
News Archive
New treatments are offering the prospect of eating without fear for the 15 million people in the United States with food allergies, according to the cover story in the current issue of Chemical & Engineering News.
A new Tel Aviv University study pinpoints the inverse correlation between a known oncogene - a gene that promotes the development of cancer - and the expression of an oncosuppressor microRNA as the reason for extended pancreatic cancer survival.
Boston Scientific Corporation today announced that the U.S. Court of Appeals for the Federal Circuit affirmed the decision of the U.S. District Court for the District of Delaware, finding all four patents in a suit involving Johnson & Johnson to be invalid.
The cardiovascular benefits of the diabetes drug dapagliflozin extend across a wide spectrum of patients and are especially pronounced in those with reduced ejection fraction, a measure of the heart's pumping ability indicative of poor heart functioning, according to research presented at the American College of Cardiology's 68thAnnual Scientific Session.
Clinigen Group plc, the global pharmaceutical and services company, announces that its Clinical Trial Service business has extended its exclusive European clinical trial supply agreement with Accord Healthcare. Clinigen is also offering pharma companies an ‘on demand' service to Accord's products, a first for the industry.
› Verified 5 days ago
Dr. Doron Galili, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 800 W Central Rd, Arlington Heights, IL 60005 Phone: 847-227-8987 | |
Rushabh Shah, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 800 W Central Rd, Arlington Heights, IL 60005 Phone: 877-635-9229 Fax: 847-618-3259 | |
Ahtesham Hyder, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 800 W Central Rd, Arlington Heights, IL 60005 Phone: 877-635-9229 Fax: 847-618-3259 | |
Ayham Alagha, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 800 W Central Rd, Arlington Heights, IL 60005 Phone: 877-635-9229 Fax: 847-618-3259 |